Fairmount Funds Management LLC 13D and 13G filings for Catalyst Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-06-23 6:32 pm Purchase |
2025-06-13 | 13D | Catalyst Biosciences, Inc. CBIO |
Fairmount Funds Management LLC | 3,124,220 19.990% |
3,124,220 (New Position) |
Filing |